262 related articles for article (PubMed ID: 20466363)
1. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
Dorr MB; Nelson AL; Mayer PR; Ranganath RP; Norris PM; Helzner EC; Preston RA
Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
[TBL] [Abstract][Full Text] [Related]
2. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
Handa VL; Bachus KE; Johnston WW; Robboy SJ; Hammond CB
Obstet Gynecol; 1994 Aug; 84(2):215-8. PubMed ID: 8041532
[TBL] [Abstract][Full Text] [Related]
3. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
4. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
[TBL] [Abstract][Full Text] [Related]
5. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
7. Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial.
Vaccaro CM; Mutema GK; Fellner AN; Crisp CC; Estanol MV; Kleeman SD; Pauls RN
Female Pelvic Med Reconstr Surg; 2013; 19(1):34-9. PubMed ID: 23321657
[TBL] [Abstract][Full Text] [Related]
8. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
9. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
[TBL] [Abstract][Full Text] [Related]
11. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
12. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.
Manonai J; Theppisai U; Suthutvoravut S; Udomsubpayakul U; Chittacharoen A
J Obstet Gynaecol Res; 2001 Oct; 27(5):255-60. PubMed ID: 11776507
[TBL] [Abstract][Full Text] [Related]
13. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
Lynch C
J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
[TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women.
Mayer P; Tse S; Sendi M; Bourg D; Morrison D
J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800
[TBL] [Abstract][Full Text] [Related]
15. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
[TBL] [Abstract][Full Text] [Related]
17. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
Bateson DJ; Weisberg E
Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
[TBL] [Abstract][Full Text] [Related]
18. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
19. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.
Portman D; Shulman L; Yeaw J; Zeng S; Uzoigwe C; Maamari R; Iyer NN
Menopause; 2015 Nov; 22(11):1197-203. PubMed ID: 25944522
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of estradiol vaginal cream in postmenopausal women.
Dickerson J; Bressler R; Christian CD; Hermann HW
Clin Pharmacol Ther; 1979 Oct; 26(4):502-7. PubMed ID: 226306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
